Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

R E Ratner, J Rosenstock, G Boka, DRI6012 Study Investigators, Timothy Lyons

Research output: Contribution to journal › Article › peer-review

125 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences